Success Metrics

Clinical Success Rate
50.0%

Based on 5 completed trials

Completion Rate
50%(5/10)
Active Trials
7(29%)
Results Posted
100%(5 trials)
Terminated
5(21%)

Phase Distribution

Ph phase_2
17
71%
Ph phase_3
5
21%
Ph not_applicable
1
4%

Phase Distribution

0

Early Stage

17

Mid Stage

5

Late Stage

Phase Distribution23 total trials
Phase 2Efficacy & side effects
17(73.9%)
Phase 3Large-scale testing
5(21.7%)
N/ANon-phased studies
1(4.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

45.5%

5 of 11 finished

Non-Completion Rate

54.5%

6 ended early

Currently Active

7

trials recruiting

Total Trials

24

all time

Status Distribution
Active(8)
Completed(5)
Terminated(6)
Other(5)

Detailed Status

Completed5
unknown5
Terminated5
Recruiting4
Active, not recruiting3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
24
Active
7
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 217 (73.9%)
Phase 35 (21.7%)
N/A1 (4.3%)

Trials by Status

withdrawn14%
completed521%
not_yet_recruiting14%
recruiting417%
unknown521%
active_not_recruiting313%
terminated521%

Recent Activity

Clinical Trials (24)

Showing 20 of 24 trialsScroll for more
NCT07564453Phase 2

Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute Lymphoblastic Leukemia

Recruiting
NCT00602667Phase 2

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma

Active Not Recruiting
NCT07259473Phase 2

Factors Influencing Immunotherapy Response in dMMR/MSI-H Gastric/Gastroesophageal Junction Adenocarcinoma

Not Yet Recruiting
NCT02066220Phase 2

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

Active Not Recruiting
NCT06846450Phase 3

Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC

Recruiting
NCT05304468Phase 3

Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain

Active Not Recruiting
NCT01850303Phase 3

Maintenance After Induction Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung Cancer

Completed
NCT04143984Phase 2

Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma

Unknown
NCT05232552Phase 2

Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma

Unknown
NCT05062005Phase 3

ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma

Recruiting
NCT05054959Phase 2

Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence

Recruiting
NCT01491737Phase 2

A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer

Completed
NCT04296747Phase 2

Toripalimab in Combination With Chemotherapy as Induced Chemotherapy for Localized Hypopharyngeal Cancer

Unknown
NCT00167180Phase 2

Post Transplant Donor Lymphocyte Infusion

Terminated
NCT03815903Phase 3

Induction Chemotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

Unknown
NCT02519712Not Applicable

Treatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related Donors

Terminated
NCT03161548Phase 2

A Study of Tongue Conservation Surgery for Oral Tongue Cancer

Terminated
NCT02084563Phase 2

Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms

Completed
NCT00002735Phase 2

SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue

Terminated
NCT02454647

Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients

Completed

Drug Details

Intervention Type
DRUG
Total Trials
24